KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Interest Expenses (2016 - 2025)

Opko Health (OPK) has disclosed Interest Expenses for 15 consecutive years, with -$97.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses fell 782.24% year-over-year to -$97.2 million, compared with a TTM value of $111.4 million through Sep 2025, up 203.69%, and an annual FY2024 reading of $47.5 million, up 251.44% over the prior year.
  • Interest Expenses was -$97.2 million for Q4 2025 at Opko Health, down from $11.4 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $70.3 million in Q2 2025 and bottomed at -$97.2 million in Q4 2025.
  • Average Interest Expenses over 5 years is $4.6 million, with a median of $4.3 million recorded in 2021.
  • Peak annual rise in Interest Expenses hit 759.74% in 2025, while the deepest fall reached 782.24% in 2025.
  • Year by year, Interest Expenses stood at $4.3 million in 2021, then dropped by 23.35% to $3.3 million in 2022, then rose by 4.6% to $3.5 million in 2023, then skyrocketed by 312.28% to $14.2 million in 2024, then tumbled by 782.24% to -$97.2 million in 2025.
  • Business Quant data shows Interest Expenses for OPK at -$97.2 million in Q4 2025, $11.4 million in Q3 2025, and $70.3 million in Q2 2025.